195 related articles for article (PubMed ID: 36707636)
21. The Nucleolin Antagonist N6L Inhibits LINE1 Retrotransposon Activity in Non-Small Cell Lung Carcinoma Cells.
Ramos KS; Moore S; Runge I; Tavera-Garcia MA; Cascone I; Courty J; Reyes-Reyes EM
J Cancer; 2020; 11(3):733-740. PubMed ID: 31942196
[TBL] [Abstract][Full Text] [Related]
22. PIN1 genetic polymorphisms and the susceptibility of HBV-related hepatocellular carcinoma in a Guangxi population.
Huang L; Mo Z; Lao X; Zhang X; Liu Y; Sui J; Qin X; Li S
Tumour Biol; 2016 May; 37(5):6599-606. PubMed ID: 26643892
[TBL] [Abstract][Full Text] [Related]
23. Pin1 inhibition reverses the acquired resistance of human hepatocellular carcinoma cells to Regorafenib via the Gli1/Snail/E-cadherin pathway.
Wang J; Zhang N; Han Q; Lu W; Wang L; Yang D; Zheng M; Zhang Z; Liu H; Lee TH; Zhou XZ; Lu KP
Cancer Lett; 2019 Mar; 444():82-93. PubMed ID: 30583078
[TBL] [Abstract][Full Text] [Related]
24. Paired mutations abolish and restore the balanced annealing and melting activities of ORF1p that are required for LINE-1 retrotransposition.
Evans JD; Peddigari S; Chaurasiya KR; Williams MC; Martin SL
Nucleic Acids Res; 2011 Jul; 39(13):5611-21. PubMed ID: 21441536
[TBL] [Abstract][Full Text] [Related]
25. Association of nuclear localization of a long interspersed nuclear element-1 protein in breast tumors with poor prognostic outcomes.
Harris CR; Normart R; Yang Q; Stevenson E; Haffty BG; Ganesan S; Cordon-Cardo C; Levine AJ; Tang LH
Genes Cancer; 2010 Feb; 1(2):115-24. PubMed ID: 20948976
[TBL] [Abstract][Full Text] [Related]
26. Protein-nucleic acid interactions of LINE-1 ORF1p.
Naufer MN; Furano AV; Williams MC
Semin Cell Dev Biol; 2019 Feb; 86():140-149. PubMed ID: 29596909
[TBL] [Abstract][Full Text] [Related]
27. PIN1 overexpression and beta-catenin gene mutations are distinct oncogenic events in human hepatocellular carcinoma.
Pang R; Yuen J; Yuen MF; Lai CL; Lee TK; Man K; Poon RT; Fan ST; Wong CM; Ng IO; Kwong YL; Tse E
Oncogene; 2004 May; 23(23):4182-6. PubMed ID: 15064734
[TBL] [Abstract][Full Text] [Related]
28. L1-ORF1p and Ago2 are involved in a siRNA-mediated regulation for promoter activity of L1-5'UTR.
Shi L; Shi H; Lou L; Yuan X; Zhu Y
Folia Histochem Cytobiol; 2019; 57(2):56-63. PubMed ID: 31112282
[TBL] [Abstract][Full Text] [Related]
29. Deletion analysis defines distinct functional domains for protein-protein and nucleic acid interactions in the ORF1 protein of mouse LINE-1.
Martin SL; Li J; Weisz JA
J Mol Biol; 2000 Nov; 304(1):11-20. PubMed ID: 11071806
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA Biogenesis is Enhanced by Liposome-Encapsulated Pin1 Inhibitor in Hepatocellular Carcinoma.
Sun D; Tan S; Xiong Y; Pu W; Li J; Wei W; Huang C; Wei YQ; Peng Y
Theranostics; 2019; 9(16):4704-4716. PubMed ID: 31367251
[TBL] [Abstract][Full Text] [Related]
31. Retrotransposon LINE-1 bodies in the cytoplasm of piRNA-deficient mouse spermatocytes: Ribonucleoproteins overcoming the integrated stress response.
De Luca C; Gupta A; Bortvin A
PLoS Genet; 2023 Jun; 19(6):e1010797. PubMed ID: 37307272
[TBL] [Abstract][Full Text] [Related]
32. Hypomethylation of LINE1 retrotransposon in human hepatocellular carcinomas, but not in surrounding liver cirrhosis.
Takai D; Yagi Y; Habib N; Sugimura T; Ushijima T
Jpn J Clin Oncol; 2000 Jul; 30(7):306-9. PubMed ID: 11007163
[TBL] [Abstract][Full Text] [Related]
33. LINE-1 expression and retrotransposition in Barrett's esophagus and esophageal carcinoma.
Doucet-O'Hare TT; Rodić N; Sharma R; Darbari I; Abril G; Choi JA; Young Ahn J; Cheng Y; Anders RA; Burns KH; Meltzer SJ; Kazazian HH
Proc Natl Acad Sci U S A; 2015 Sep; 112(35):E4894-900. PubMed ID: 26283398
[TBL] [Abstract][Full Text] [Related]
34. Characterization of LINE-1 ribonucleoprotein particles.
Doucet AJ; Hulme AE; Sahinovic E; Kulpa DA; Moldovan JB; Kopera HC; Athanikar JN; Hasnaoui M; Bucheton A; Moran JV; Gilbert N
PLoS Genet; 2010 Oct; 6(10):. PubMed ID: 20949108
[TBL] [Abstract][Full Text] [Related]
35. Detection of the LINE-1 retrotransposon RNA-binding protein ORF1p in different anatomical regions of the human brain.
Sur D; Kustwar RK; Budania S; Mahadevan A; Hancks DC; Yadav V; Shankar SK; Mandal PK
Mob DNA; 2017; 8():17. PubMed ID: 29201157
[TBL] [Abstract][Full Text] [Related]
36. Endogenous retrotransposition activates oncogenic pathways in hepatocellular carcinoma.
Shukla R; Upton KR; Muñoz-Lopez M; Gerhardt DJ; Fisher ME; Nguyen T; Brennan PM; Baillie JK; Collino A; Ghisletti S; Sinha S; Iannelli F; Radaelli E; Dos Santos A; Rapoud D; Guettier C; Samuel D; Natoli G; Carninci P; Ciccarelli FD; Garcia-Perez JL; Faivre J; Faulkner GJ
Cell; 2013 Mar; 153(1):101-11. PubMed ID: 23540693
[TBL] [Abstract][Full Text] [Related]
37. Characterizing Complex Nucleic Acid Interactions of LINE1 ORF1p by Single Molecule Force Spectroscopy.
Naufer MN; Williams MC
Methods Mol Biol; 2020; 2106():283-297. PubMed ID: 31889265
[TBL] [Abstract][Full Text] [Related]
38. Targeting Pin1 by inhibitor API-1 regulates microRNA biogenesis and suppresses hepatocellular carcinoma development.
Pu W; Li J; Zheng Y; Shen X; Fan X; Zhou JK; He J; Deng Y; Liu X; Wang C; Yang S; Chen Q; Liu L; Zhang G; Wei YQ; Peng Y
Hepatology; 2018 Aug; 68(2):547-560. PubMed ID: 29381806
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of CDK-mediated Smad3 phosphorylation reduces the Pin1-Smad3 interaction and aggressiveness of triple negative breast cancer cells.
Thomas AL; Lind H; Hong A; Dokic D; Oppat K; Rosenthal E; Guo A; Thomas A; Hamden R; Jeruss JS
Cell Cycle; 2017 Aug; 16(15):1453-1464. PubMed ID: 28678584
[TBL] [Abstract][Full Text] [Related]
40. PIN1 expression contributes to hepatic carcinogenesis.
Pang RW; Lee TK; Man K; Poon RT; Fan ST; Kwong YL; Tse E
J Pathol; 2006 Sep; 210(1):19-25. PubMed ID: 16841372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
